Report Detail
Global VLP-based Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4696390 |
- 21 May, 2026 |
- Global |
- 86 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global VLP-based Vaccine market size was valued at US$ 689 million in 2025 and is forecast to a readjusted size of US$ 1190 million by 2032 with a CAGR of 8.2% during review period.
Virus-like particles (VLPs) have evolved to become a widely accepted technology, especially in the field of vaccinology. In fact, some VLP-based vaccines are currently used as commercial medical products, and other VLP-based products are at different stages of clinical study. Several remarkable advantages have been achieved in the development of VLPs as gene therapy tools and new nanomaterials. In recent years, the technologies develop very fast that are used to characterize the structural integrity, stability, and components, including the encapsidated nucleic acids, of newly synthesized VLPs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global VLP-based Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global VLP-based Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global VLP-based Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global VLP-based Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global VLP-based Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for VLP-based Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global VLP-based Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck and Co., GlaxoSmithKline, Pfizer, Dynavax Technologies, Sanofi, Wantai BioPharm, Serum Institute of India, Bharat Biotech, LG Chem, VBI Vaccines, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
VLP-based Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Live-Attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Toxoid Vaccines
Market segment by Application
Hepatitis
HPV
Others
Major players covered
Merck and Co.
GlaxoSmithKline
Pfizer
Dynavax Technologies
Sanofi
Wantai BioPharm
Serum Institute of India
Bharat Biotech
LG Chem
VBI Vaccines
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe VLP-based Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of VLP-based Vaccine, with price, sales quantity, revenue, and global market share of VLP-based Vaccine from 2021 to 2026.
Chapter 3, the VLP-based Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the VLP-based Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and VLP-based Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of VLP-based Vaccine.
Chapter 14 and 15, to describe VLP-based Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global VLP-based Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Live-Attenuated Vaccines
- 1.3.3 Inactivated Vaccines
- 1.3.4 Recombinant Vaccines
- 1.3.5 Toxoid Vaccines
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global VLP-based Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hepatitis
- 1.4.3 HPV
- 1.4.4 Others
- 1.5 Global VLP-based Vaccine Market Size & Forecast
- 1.5.1 Global VLP-based Vaccine Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global VLP-based Vaccine Sales Quantity (2021-2032)
- 1.5.3 Global VLP-based Vaccine Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Merck and Co.
- 2.1.1 Merck and Co. Details
- 2.1.2 Merck and Co. Major Business
- 2.1.3 Merck and Co. VLP-based Vaccine Product and Services
- 2.1.4 Merck and Co. VLP-based Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Merck and Co. Recent Developments/Updates
- 2.2 GlaxoSmithKline
- 2.2.1 GlaxoSmithKline Details
- 2.2.2 GlaxoSmithKline Major Business
- 2.2.3 GlaxoSmithKline VLP-based Vaccine Product and Services
- 2.2.4 GlaxoSmithKline VLP-based Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 GlaxoSmithKline Recent Developments/Updates
- 2.3 Pfizer
- 2.3.1 Pfizer Details
- 2.3.2 Pfizer Major Business
- 2.3.3 Pfizer VLP-based Vaccine Product and Services
- 2.3.4 Pfizer VLP-based Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Pfizer Recent Developments/Updates
- 2.4 Dynavax Technologies
- 2.4.1 Dynavax Technologies Details
- 2.4.2 Dynavax Technologies Major Business
- 2.4.3 Dynavax Technologies VLP-based Vaccine Product and Services
- 2.4.4 Dynavax Technologies VLP-based Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Dynavax Technologies Recent Developments/Updates
- 2.5 Sanofi
- 2.5.1 Sanofi Details
- 2.5.2 Sanofi Major Business
- 2.5.3 Sanofi VLP-based Vaccine Product and Services
- 2.5.4 Sanofi VLP-based Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Sanofi Recent Developments/Updates
- 2.6 Wantai BioPharm
- 2.6.1 Wantai BioPharm Details
- 2.6.2 Wantai BioPharm Major Business
- 2.6.3 Wantai BioPharm VLP-based Vaccine Product and Services
- 2.6.4 Wantai BioPharm VLP-based Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Wantai BioPharm Recent Developments/Updates
- 2.7 Serum Institute of India
- 2.7.1 Serum Institute of India Details
- 2.7.2 Serum Institute of India Major Business
- 2.7.3 Serum Institute of India VLP-based Vaccine Product and Services
- 2.7.4 Serum Institute of India VLP-based Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Serum Institute of India Recent Developments/Updates
- 2.8 Bharat Biotech
- 2.8.1 Bharat Biotech Details
- 2.8.2 Bharat Biotech Major Business
- 2.8.3 Bharat Biotech VLP-based Vaccine Product and Services
- 2.8.4 Bharat Biotech VLP-based Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Bharat Biotech Recent Developments/Updates
- 2.9 LG Chem
- 2.9.1 LG Chem Details
- 2.9.2 LG Chem Major Business
- 2.9.3 LG Chem VLP-based Vaccine Product and Services
- 2.9.4 LG Chem VLP-based Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 LG Chem Recent Developments/Updates
- 2.10 VBI Vaccines
- 2.10.1 VBI Vaccines Details
- 2.10.2 VBI Vaccines Major Business
- 2.10.3 VBI Vaccines VLP-based Vaccine Product and Services
- 2.10.4 VBI Vaccines VLP-based Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 VBI Vaccines Recent Developments/Updates
3 Competitive Environment: VLP-based Vaccine by Manufacturer
- 3.1 Global VLP-based Vaccine Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global VLP-based Vaccine Revenue by Manufacturer (2021-2026)
- 3.3 Global VLP-based Vaccine Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of VLP-based Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 VLP-based Vaccine Manufacturer Market Share in 2025
- 3.4.3 Top 6 VLP-based Vaccine Manufacturer Market Share in 2025
- 3.5 VLP-based Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 VLP-based Vaccine Market: Region Footprint
- 3.5.2 VLP-based Vaccine Market: Company Product Type Footprint
- 3.5.3 VLP-based Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global VLP-based Vaccine Market Size by Region
- 4.1.1 Global VLP-based Vaccine Sales Quantity by Region (2021-2032)
- 4.1.2 Global VLP-based Vaccine Consumption Value by Region (2021-2032)
- 4.1.3 Global VLP-based Vaccine Average Price by Region (2021-2032)
- 4.2 North America VLP-based Vaccine Consumption Value (2021-2032)
- 4.3 Europe VLP-based Vaccine Consumption Value (2021-2032)
- 4.4 Asia-Pacific VLP-based Vaccine Consumption Value (2021-2032)
- 4.5 South America VLP-based Vaccine Consumption Value (2021-2032)
- 4.6 Middle East & Africa VLP-based Vaccine Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global VLP-based Vaccine Sales Quantity by Type (2021-2032)
- 5.2 Global VLP-based Vaccine Consumption Value by Type (2021-2032)
- 5.3 Global VLP-based Vaccine Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global VLP-based Vaccine Sales Quantity by Application (2021-2032)
- 6.2 Global VLP-based Vaccine Consumption Value by Application (2021-2032)
- 6.3 Global VLP-based Vaccine Average Price by Application (2021-2032)
7 North America
- 7.1 North America VLP-based Vaccine Sales Quantity by Type (2021-2032)
- 7.2 North America VLP-based Vaccine Sales Quantity by Application (2021-2032)
- 7.3 North America VLP-based Vaccine Market Size by Country
- 7.3.1 North America VLP-based Vaccine Sales Quantity by Country (2021-2032)
- 7.3.2 North America VLP-based Vaccine Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe VLP-based Vaccine Sales Quantity by Type (2021-2032)
- 8.2 Europe VLP-based Vaccine Sales Quantity by Application (2021-2032)
- 8.3 Europe VLP-based Vaccine Market Size by Country
- 8.3.1 Europe VLP-based Vaccine Sales Quantity by Country (2021-2032)
- 8.3.2 Europe VLP-based Vaccine Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific VLP-based Vaccine Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific VLP-based Vaccine Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific VLP-based Vaccine Market Size by Region
- 9.3.1 Asia-Pacific VLP-based Vaccine Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific VLP-based Vaccine Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America VLP-based Vaccine Sales Quantity by Type (2021-2032)
- 10.2 South America VLP-based Vaccine Sales Quantity by Application (2021-2032)
- 10.3 South America VLP-based Vaccine Market Size by Country
- 10.3.1 South America VLP-based Vaccine Sales Quantity by Country (2021-2032)
- 10.3.2 South America VLP-based Vaccine Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa VLP-based Vaccine Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa VLP-based Vaccine Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa VLP-based Vaccine Market Size by Country
- 11.3.1 Middle East & Africa VLP-based Vaccine Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa VLP-based Vaccine Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 VLP-based Vaccine Market Drivers
- 12.2 VLP-based Vaccine Market Restraints
- 12.3 VLP-based Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of VLP-based Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of VLP-based Vaccine
- 13.3 VLP-based Vaccine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 VLP-based Vaccine Typical Distributors
- 14.3 VLP-based Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on VLP-based Vaccine. Industry analysis & Market Report on VLP-based Vaccine is a syndicated market report, published as Global VLP-based Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of VLP-based Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
